In short
This article discusses the use of Desvenlafaxine Benzoate in clinical trials for treating major depressive disorder. Desvenlafaxine Benzoate is being studied as part of an early intensified pharmacological treatment approach for patients who have experienced a first-time treatment failure with their initial medication. The trial aims to compare this new approach with standard treatment methods to determine its effectiveness in managing depression symptoms.
At a glance
- Study Drug
- Desvenlafaxine Benzoate
- Condition Studied
- Major Depressive Disorder
- Primary Objective
- Compare early intensified pharmacological treatment (EIPT) to treatment as usual (TAU) in patients with first-time treatment failure
- Main Outcome Measure
- Change in Montgomery Åsberg Depression Rating Scale (MADRS) score
- Treatment Duration
- 6 weeks
- Maximum Daily Dose
- 200 mg
- Administration Route
- Oral
- Key Inclusion Criteria
- Age 18-65, diagnosed with major depressive disorder, first treatment failure
- Key Exclusion Criteria
- Pregnancy, substance use disorder, previous ketamine use for depression
What is Desvenlafaxine?
Desvenlafaxine Benzoate is a medication used in the treatment of major depressive disorder (MDD). It belongs to a class of drugs known as serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of two important neurotransmitters, serotonin and norepinephrine, in the brain, which can help improve mood and emotional well-being.
Medical Use
Desvenlafaxine is primarily used to treat major depressive disorder, a serious mental health condition characterized by persistent feelings of sadness, hopelessness, and loss of interest in daily activities. It is often prescribed when other first-line treatments for depression have not been effective.
Administration
Desvenlafaxine is typically administered orally, meaning it is taken by mouth. It comes in a tablet form, which makes it convenient for patients to take as prescribed by their healthcare provider.
Dosage
The dosage of Desvenlafaxine can vary depending on the individual patient's needs and response to treatment. According to the clinical trial information, the maximum daily dose of Desvenlafaxine used in the study was 200 mg. However, it's important to note that your doctor will determine the appropriate dosage for you based on your specific condition and other factors.
Clinical Trial Information
Desvenlafaxine Benzoate is being studied as part of a clinical trial comparing different treatment approaches for major depressive disorder. The trial is specifically looking at patients who have not responded well to their first treatment for depression. In this study, Desvenlafaxine is considered a "comparator" medication, which means it's being used as a standard treatment to compare against other interventions.
Potential Benefits
While the specific outcomes of the trial are not yet known, the study aims to evaluate several potential benefits of treatment, including:
- Reduction in depression symptoms
- Improvement in overall functioning and quality of life
- Reduction in anxiety symptoms
- Improvement in cognitive performance
These potential benefits are being measured using various standardized scales and tests throughout the course of the study.
Considerations and Precautions
As with any medication, there are important considerations and precautions to keep in mind when taking Desvenlafaxine:
- It should not be used by pregnant or breastfeeding women without consulting a doctor
- Patients with a history of substance use disorders should discuss this with their healthcare provider
- It may interact with other medications, so it's important to inform your doctor about all medications you're taking
- Regular check-ups and monitoring may be necessary to assess the medication's effectiveness and any potential side effects
It's crucial to take Desvenlafaxine exactly as prescribed by your healthcare provider and to discuss any concerns or side effects you may experience.